Racivir

Racivir
Clinical data

Routes of administration	Investigational
ATC code	none
Identifiers
IUPAC name 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one
CAS Number	137530-41-7
PubChem CID	454858
ChemSpider	400521
NIAID ChemDB	005245
Chemical and physical data
Formula	C₈H₁₀FN₃O₃S
Molar mass	247.25 g/mol
3D model (JSmol)	Interactive image
SMILES c1c(c(nc(=O)n1[C@H]2CS[C@H](O2)CO)N)F
InChI InChI=1S/C8H10FN3O3S/c9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5/h1,5-6,13H,2-3H2,(H2,10,11,14)/t5-,6+/m1/s1 Key:XQSPYNMVSIKCOC-RITPCOANSA-N

Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.